{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:32:57Z","timestamp":1793413977200,"version":"4.5.0"},"reference-count":56,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Genomic profiling during the diagnosis of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in adults is used to guide disease classification, risk stratification, and treatment decisions. Patients for whom diagnostic screening fails to identify disease-defining or risk-stratifying lesions are classified as having B-other ALL. We screened a cohort of 652 BCP-ALL cases enrolled in UKALL14 to identify and perform whole genome sequencing (WGS) of paired tumor-normal samples. For 52 patients with B-other, we compared the WGS findings with data from clinical and research cytogenetics. WGS identified a cancer-associated event in 51 of 52 patients, including an established subtype defining genetic alterations that were previously missed with standard-of-care (SoC) genetics in 5 of them. Of the 47 true B-other ALL, we identified a recurrent driver in 87% (41). A complex karyotype via cytogenetics emerges as a heterogeneous group, including distinct genetic alterations associated with either favorable (DUX4-r) or poor outcomes (MEF2D-r and IGK::BCL2). For a subset of 31 cases, we integrated the findings from RNA sequencing (RNA-seq) analysis to include fusion gene detection and classification based on gene expression. Compared with RNA-seq, WGS was sufficient to detect and resolve recurrent genetic subtypes; however, RNA-seq can provide orthogonal validation of findings. In conclusion, we demonstrated that WGS can identify clinically relevant genetic abnormalities missed with SoC testing as well as identify leukemia driver events in virtually all cases of B-other ALL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008992","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T18:07:52Z","timestamp":1677866872000},"page":"3862-3873","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":31,"title":["Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"7","author":[{"given":"Daniel","family":"Leongamornlert","sequence":"first","affiliation":[{"name":"1Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-5876","authenticated-orcid":false,"given":"Jes\u00fas","family":"Guti\u00e9rrez-Abril","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SooWah","family":"Lee","sequence":"additional","affiliation":[{"name":"3Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Barretta","sequence":"additional","affiliation":[{"name":"4Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Creasey","sequence":"additional","affiliation":[{"name":"4Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunes","family":"Gundem","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5156-9086","authenticated-orcid":false,"given":"Max F.","family":"Levine","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1109-6178","authenticated-orcid":false,"given":"Juan E.","family":"Arango-Ossa","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Liosis","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8444-153X","authenticated-orcid":false,"given":"Juan S.","family":"Medina-Martinez","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Zuborne Alapi","sequence":"additional","affiliation":[{"name":"3Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy A.","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"5Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Clifton-Hadley","sequence":"additional","affiliation":[{"name":"5Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pip","family":"Patrick","sequence":"additional","affiliation":[{"name":"5Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0407-0386","authenticated-orcid":false,"given":"David","family":"Jones","sequence":"additional","affiliation":[{"name":"1Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"1Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Butler","sequence":"additional","affiliation":[{"name":"1Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Harrison","sequence":"additional","affiliation":[{"name":"4Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Campbell","sequence":"additional","affiliation":[{"name":"1Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Patel","sequence":"additional","affiliation":[{"name":"6Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9781-6107","authenticated-orcid":false,"given":"Anthony V.","family":"Moorman","sequence":"additional","affiliation":[{"name":"4Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4746-7789","authenticated-orcid":false,"given":"Adele K.","family":"Fielding","sequence":"additional","affiliation":[{"name":"3Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elli","family":"Papaemmanuil","sequence":"additional","affiliation":[{"name":"2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"issue":"16","key":"2023080716253504000_bib1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood.2019001244","article-title":"Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements","volume":"134","author":"Tanasi","year":"2019","journal-title":"Blood"},{"issue":"8","key":"2023080716253504000_bib2","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2023080716253504000_bib3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3324\/haematol.2012.081877","article-title":"The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)\/MLL-AFF1 prospectively treated in the UKALLXII\/ECOG2993 trial","volume":"98","author":"Marks","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"2023080716253504000_bib4","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1016\/S2352-3026(22)00038-2","article-title":"Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial","volume":"9","author":"Marks","year":"2022","journal-title":"Lancet Haematol"},{"issue":"5","key":"2023080716253504000_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3535","article-title":"Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults","volume":"48","author":"Yasuda","year":"2016","journal-title":"Nat Genet"},{"key":"2023080716253504000_bib6","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1038\/ncomms11790","article-title":"Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia","volume":"7","author":"Lilljebj\u00f6rn","year":"2016","journal-title":"Nat Commun"},{"key":"2023080716253504000_bib7","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1038\/ncomms13331","article-title":"Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia","volume":"7","author":"Gu","year":"2016","journal-title":"Nat Commun"},{"issue":"50","key":"2023080716253504000_bib8","doi-asserted-by":"crossref","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2023080716253504000_bib9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"issue":"3","key":"2023080716253504000_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41375-021-01448-2","article-title":"Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study","volume":"36","author":"Moorman","year":"2022","journal-title":"Leukemia"},{"issue":"21","key":"2023080716253504000_bib11","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"Ye","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"2023080716253504000_bib12","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","article-title":"The life history of 21 breast cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"issue":"7605","key":"2023080716253504000_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"key":"2023080716253504000_bib14","doi-asserted-by":"crossref","first-page":"15.10.1","DOI":"10.1002\/cpbi.20","article-title":"cgpCaVEManWrapper: simple execution of CaVEMan in Order to detect somatic single nucleotide variants in NGS data","volume":"56","author":"Jones","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"key":"2023080716253504000_bib15","doi-asserted-by":"crossref","first-page":"15.9.1","DOI":"10.1002\/cpbi.17","article-title":"ascatNgs: Identifying somatically acquired copy-number alterations from whole-genome sequencing data","volume":"56","author":"Raine","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"key":"2023080716253504000_bib16","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"2023080716253504000_bib17","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.01.454393","article-title":"ALLSorts: a RNA-seq classifier for B-cell acute lymphoblastic leukemia","author":"Schmidt","year":"2021","journal-title":"bioRxiv"},{"issue":"9","key":"2023080716253504000_bib18","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.3390\/ijms23094574","article-title":"Multi-cohort transcriptomic subtyping of B-cell acute lymphoblastic leukemia","volume":"23","author":"M\u00e4kinen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2023080716253504000_bib19","first-page":"011650","article-title":"FusionCatcher \u2013 a tool for finding somatic fusion genes in paired-end RNA-sequencing data","author":"Nicorici","year":"2014","journal-title":"bioRxiv"},{"issue":"1","key":"2023080716253504000_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13059-020-02043-x","article-title":"CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data","volume":"21","author":"Tian","year":"2020","journal-title":"Genome Biol"},{"issue":"1","key":"2023080716253504000_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2023080716253504000_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/s12859-020-03879-7","article-title":"Isabl platform, a digital biobank for processing multimodal patient data","volume":"21","author":"Medina-Mart\u00ednez","year":"2020","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"2023080716253504000_bib23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"issue":"D1","key":"2023080716253504000_bib24","doi-asserted-by":"crossref","first-page":"D766","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"database issue","key":"2023080716253504000_bib25","first-page":"D920","article-title":"Atlas of genetics and cytogenetics in oncology and haematology in 2013","volume":"41","author":"Huret","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2023080716253504000_bib26","volume-title":"Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer","year":"2023"},{"issue":"12","key":"2023080716253504000_bib27","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1101\/gr.222109.117","article-title":"GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly","volume":"27","author":"Cameron","year":"2017","journal-title":"Genome Res"},{"issue":"4","key":"2023080716253504000_bib28","first-page":"656","article-title":"BLAT--the BLAST-like alignment tool","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res"},{"issue":"1","key":"2023080716253504000_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-018-0539-0","article-title":"MutationalPatterns: comprehensive genome-wide analysis of mutational processes","volume":"10","author":"Blokzijl","year":"2018","journal-title":"Genome Med"},{"issue":"7924","key":"2023080716253504000_bib30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41586-022-05072-7","article-title":"Diverse mutational landscapes in human lymphocytes","volume":"608","author":"Machado","year":"2022","journal-title":"Nature"},{"issue":"2","key":"2023080716253504000_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ng.2874","article-title":"RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia","volume":"46","author":"Papaemmanuil","year":"2014","journal-title":"Nat Genet"},{"issue":"W1","key":"2023080716253504000_bib32","doi-asserted-by":"crossref","first-page":"W39","DOI":"10.1093\/nar\/gkv416","article-title":"The MEME Suite","volume":"43","author":"Bailey","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2023080716253504000_bib33","volume-title":"R: a language and environment for statistical computing","author":"R Foundation for Statistical Computing","year":"2020"},{"key":"2023080716253504000_bib34","volume-title":"Statistic and Computing","author":"Venables","year":"2002"},{"issue":"10","key":"2023080716253504000_bib35","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/ajh.25617","article-title":"World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management","volume":"94","author":"Shomali","year":"2019","journal-title":"Am J Hematol"},{"issue":"2","key":"2023080716253504000_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"issue":"7494","key":"2023080716253504000_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature13115","article-title":"Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia","volume":"508","author":"Li","year":"2014","journal-title":"Nature"},{"issue":"12","key":"2023080716253504000_bib38","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"},{"issue":"11","key":"2023080716253504000_bib39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.2020010144","article-title":"Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL","volume":"138","author":"Paietta","year":"2021","journal-title":"Blood"},{"issue":"24","key":"2023080716253504000_bib40","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1182\/blood.2022015444","article-title":"Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia","volume":"139","author":"Kimura","year":"2022","journal-title":"Blood"},{"issue":"12","key":"2023080716253504000_bib41","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood.2021011921","article-title":"Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1\/2 mutations","volume":"139","author":"Yasuda","year":"2022","journal-title":"Blood"},{"issue":"7463","key":"2023080716253504000_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"1","key":"2023080716253504000_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"2023080716253504000_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","article-title":"Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia","volume":"8","author":"Liu","year":"2016","journal-title":"EBioMedicine"},{"issue":"7724","key":"2023080716253504000_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","article-title":"Population dynamics of normal human blood inferred from somatic mutations","volume":"561","author":"Lee-Six","year":"2018","journal-title":"Nature"},{"issue":"14","key":"2023080716253504000_bib46","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2018-05-852566","article-title":"MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML","volume":"132","author":"Sanders","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2023080716253504000_bib47","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1101\/gr.226845.117","article-title":"Mutational signatures of DNA mismatch repair deficiency in C.\u00a0elegans and human cancers","volume":"28","author":"Meier","year":"2018","journal-title":"Genome Res"},{"issue":"1","key":"2023080716253504000_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/0008-5472.BCD-19-0041","article-title":"Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia","volume":"1","author":"Waanders","year":"2020","journal-title":"Blood Cancer Discov"},{"issue":"8","key":"2023080716253504000_bib49","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s43018-021-00230-8","article-title":"Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse","volume":"2","author":"Yang","year":"2021","journal-title":"Nat Cancer"},{"issue":"7354","key":"2023080716253504000_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"2023080716253504000_bib51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41375-022-01799-4","article-title":"Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial","volume":"37","author":"Schwab","year":"2023","journal-title":"Leukemia"},{"key":"2023080716253504000_bib52","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41375-022-01806-8","article-title":"Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia","volume":"37","author":"Ryan","year":"2023","journal-title":"Leukemia"},{"issue":"3","key":"2023080716253504000_bib53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41588-021-00779-1","article-title":"Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion","volume":"53","author":"Frangieh","year":"2021","journal-title":"Nat Genet"},{"key":"2023080716253504000_bib54","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.21.485049","article-title":"The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity","author":"Ho","year":"2022","journal-title":"bioRxiv"},{"issue":"22","key":"2023080716253504000_bib55","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1182\/bloodadvances.2022007891","article-title":"CD58 loss in tumor cells confers functional impairment of CAR T cells","volume":"6","author":"Yan","year":"2022","journal-title":"Blood Adv"},{"issue":"suppl 1","key":"2023080716253504000_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2020-139605","article-title":"CD58 aberrations limit durable responses to CD19 CAR in large B Cell lymphoma patients treated with axicabtagene ciloleucel but can be overcome through novel CAR engineering","volume":"136","author":"Majzner","year":"2020","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/3862\/2069564\/blooda_adv-2022-008992-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/3862\/2069564\/blooda_adv-2022-008992-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T16:26:18Z","timestamp":1691425578000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/15\/3862\/494801\/Diagnostic-utility-of-whole-genome-sequencing-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":56,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,8,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008992","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}